Cervix, Uterus, Ovaries, Vagina Flashcards
When to start pap smear
Within 3 years of onset of sexual activity At 21 years old
How often does a woman need to undergo pap smear?
When to discontinue pap smear?
65-70 years old provided that negative for 3 consecutive years No abnormal results for the past 10 years, no new sexual partner Post hysterectomy
Management of CIN 1 biopsy result
Evaluation for squamous cell abnormalities in Pap smear
Colposcopy
Management of CIN 2,3 biopsy result
Colposcopy, excision or ablation of transformation zone
2nd most common cancer among women
Cervical
Necessary cause of cervical cancer
HPV
Most common type of cervical cancer
Squamous cell CA
Squamous cell CA of the cervix arises from what structure
Ectocervix
Most common symptom in cervical cancer
Vaginal bleeding
Cervical cancer stage where lower 1/3 of the vagina is affected
Stage 3
Cervical cancer stage where it extends beyond the cervix but not pelvic wall or lower third of vagina
Stage 2
Cervical cancer stage where there is bladder or rectal invasion
Stage 4
First line combination chemotherapy for cervical cancer
Cisplatin Paclitaxel
Single agent chemotherapy for cervical cancer
Cisplatin
Treatment for stage 1 cervical cancer if not desirous of pregnancy
Hysterectomy
Treatment of cervical cancer from stage 2 onwards
Chemotherapy
MANAGEMENT FOR PREMENOPAUSAL WOMEN: Hyperplasia WITH atypia
- If desirous of pregnancy
- Continuous MPA 10-20mg OD x 3 months
- Megestrol acetate 40-200mg OD
- DMPA 150mg every 3 months
- LNG-IUS for 1-5 years
- Do UTS & sample endometrium after 3 mos:
- Normal: decrease MPA 10mg OD x 14 days for 12 more months
- Persistent: increase MPA to 40-100mg daily for 3 months, OR shift to Megestrol acetate 40mg 2-4x a day for 3 months then repeat biopsy, if persistent: EH +/- BSO
- No desire for pregnancy: EH +/- BSO
MANAGEMENT FOR PREMENOPAUSAL WOMEN: Hyperplasia WITHOUT atypia
- For simple hyperplasia: OCP x 6 cycles
- MPA 10-20 mg OD x 14 days
- Do UTS & sample endometrium after 3 mos:
- Normal: MPA, 5mg x 10days/month for 12 months
- Persistent: increase dose 40-100mg daily for 3 months, then repeat biopsy
MANAGEMENT FOR POSTMENOPAUSAL WOMEN: Endometrial Hyperplasia WITHOUT atypia
- If desirous for uterine preservation, of if poor surgical risk, same as in premenopausal
- If not desirous of uterine preservation, EHBSO
Treatment for endometrial hyperplasia with atypia for postmenopausal
EHBSO
Most common type of endometrial CA
Adenocarcinoma
Stage of endometrial cancer reaching the cervix
Stage 2
Stage of endometrial cancer outside the uterus
Stage 3
Stage of endometrial cancer reaching the bladder
Stage 4
Treatment for endometrial cancer
EHBSO Chemotherapy if stage 3
Most popular theory for endometriosis
Retrograde menstruation
Classic symptoms of endometriosis
Cyclic pelvic pain and infertility
Classic PE finding in endometriosis
Fixed retroverted uterus with scarring and tenderness posteriorly
Definitive treatment for endometriosis
Hysterectomy
Medical treatment for endometriosis to induce pseudomenopause
Danazol-atrophic changes to implants GnRH agonists like leuprolide OCP, NSAID Aromatase inhibitors like letrozole
Size of the ovaries that may suggest malignancy
>8cm
Most common cause of simple cystic adnexal mass in the reproductive age
Functional cyst
Most common cause of complex adnexal mass
Benign cystic teratoma
Most common cause of pelvic mass
Pregnancy
This type of ovarian cyst can rupture and cause intraperitoneal bleeding
Corpus luteum cyst
This ovarian cyst can cause adnexal torsion and massive bleeding
Theca lutein cyst